Toshima-ku, Japan

Youichi Shimazaki

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Toshima-ku, JP (2014 - 2015)
  • Tokyo, JP (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Youichi Shimazaki: Innovator in Pharmaceutical Development

Introduction

Youichi Shimazaki is a notable inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for various mental and physical health disorders. With a total of 3 patents to his name, Shimazaki's work is recognized for its potential impact on healthcare.

Latest Patents

Shimazaki's latest patents focus on azole derivatives that provide agents for treating or preventing a wide range of diseases. These include mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, gastrointestinal diseases, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injuries, inflammation, immune-related diseases, and alopecia. His inventions specifically target the arginine-vasopressin (AVP) V1b receptor, showcasing a novel approach to pharmacological intervention.

Career Highlights

Currently, Youichi Shimazaki is associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving therapeutic outcomes for patients suffering from complex health issues.

Collaborations

Shimazaki collaborates with esteemed colleagues, including Mitsukane Yoshinaga and Takeshi Kuwada. Their combined expertise enhances the research and development efforts at Taisho Pharmaceutical Co., Ltd.

Conclusion

Youichi Shimazaki's contributions to pharmaceutical innovation are noteworthy, particularly in the development of treatments for serious health conditions. His ongoing work promises to advance the field and improve patient care significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…